JAGX
NASDAQ · Pharmaceuticals
Jaguar Health Inc
$3.00
+0.02 (+0.67%)
Open$2.96
Previous Close$2.98
Day High$3.28
Day Low$2.80
52W High$395.98
52W Low—
Volume—
Avg Volume149.5K
Market Cap1.20M
P/E Ratio—
EPS$-37.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,496.7% upside
Current
$3.00
$3.00
Target
$47.90
$47.90
$35.39
$47.90 avg
$54.68
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.98M | 2.01M | 728.2K |
| Net Income | -9,192,740 | -8,379,041 | 171.9K |
| Profit Margin | -464.2% | -441.0% | 23.6% |
| EBITDA | -7,870,973 | -7,572,842 | 249.9K |
| Free Cash Flow | — | — | 132.1K |
| Rev Growth | -1.3% | -1.3% | -5.9% |
| Debt/Equity | 3.64 | 3.64 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |